KMTS Earnings KESTRA MEDICAL TECHNOLOGIES, LTD.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–12 of 12
| Q1 2026 | 2026-07-31 | -0.75 | 2026-09-14 | 10-Q |
| Q4 2026 (derived) | 2026-04-30 | -0.68 | 2026-07-14 | 10-K |
| FY 2026 | 2026-04-30 | -2.43 | 2026-07-14 | 10-K |
| Q3 2026 | 2026-01-31 | -0.61 | 2026-03-17 | 10-Q |
| Q2 2025 | 2025-10-31 | -0.64 | 2025-12-11 | 10-Q |
| Q1 2025 | 2025-07-31 | -0.50 | 2025-09-12 | 10-Q |
| Q4 2025 (derived) | 2025-04-30 | -1.57 | 2025-07-17 | 10-K |
| FY 2025 | 2025-04-30 | -5.13 | 2025-07-17 | 10-K |
| Q3 2025 | 2025-01-31 | -1.25 | — | — |
| Q2 2024 | 2024-10-31 | -1.19 | — | — |
| Q1 2024 | 2024-07-31 | -1.12 | — | — |
| FY 2024 | 2024-04-30 | -5.07 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.